InvestLog
HYFT logo

HYFT

MindWalk Holdings Corp.NASDAQHealthcare
$1.14+0.00%ClosedMarket Cap: $53.3M

As of 2026-04-06

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

4.88

P/S

4.03

EV/EBITDA

-5.91

DCF Value

$-5.86

FCF Yield

-16.2%

Div Yield

0.0%

Margins & Returns

Gross Margin

59.7%

Operating Margin

-66.0%

Net Margin

-66.8%

ROE

-63.1%

ROA

-52.5%

ROIC

-63.4%

Financials

View All
PeriodRevenueNet IncomeEPS
Q3 2026$4.1M$-3.9M$-0.08
Q2 2026$4.2M$-3.2M$-0.07
Q1 2026$3.2M$-3.0M$-0.07
Q4 2025$6.8M$-2.1M$-0.06

Trading Activity

Insider Trades

View All
Aisling Capital II LP10 percent owner
SellMon Mar 03
Aisling Capital II LP10 percent owner
SellMon Mar 03
Aisling Capital II LP10 percent owner
SellMon Mar 03
Aisling Capital II LP10 percent owner
SellMon Mar 03
TULLIS DICKERSON CAPITAL FOCUS III, L.P.10 percent owner
SellFri Feb 29

Company Info

Sector

Healthcare

Industry

—

Country

CA

Exchange

NASDAQ

Beta

0.64

MindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics. The company, through its LensAI platform and HYFT technology, it partners with pharmaceutical and biotechnology companies to drive de-risk drug development and unlock therapeutic possibilities. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.

Peers

ALXOATYRBYSICAMPCLNNFBIOGUTSQNCX